CLINICAL ROLE -
Biosimilars in Specialty Pharmacy
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.
Watch
Optimal Management Programs Vital to Specialty Patient Success
Rebekah L. Hanson, PharmD, BCPS, BCACP, discusses the elements of an effective patient management program in specialty pharmacy.
Overcoming High Out-of-Pocket Costs in Specialty Pharmacy
Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how pharmacies can help patients manage high drug costs.
Managing Effective Specialty Drug Distribution
Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses optimal support for distribution of specialty therapies.
Alignment Between Specialty Pharmacy and ACOs
Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses how specialty pharmacies can help achieve the goals of accountable care organizations.
Helping Patients Manage High Medication Co-pays
Deborah Michaelson, MS, RPh, vice president of Operations at Ardon Health, discusses how pharmacies can help patients overcome the cost of high co-pays to maintain specialty drug adherence.
Limitations in Prior Authorizations for Specialty Drugs
Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses the impact of prior authorizations on specialty pharmacy.
How Will Drug Costs Impact the Specialty Pharmacy Patient Experience?
Grant E. Knowles, PharmD, discusses how the projected growth in specialty drug spending may change the patient experience in the years ahead.
How to Improve Adherence to Specialty Drugs
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how to optimize a drug adherence program in specialty pharmacy.
Are There Interactions Between Certain Medications, Nutraceuticals That Pharmacists Should Counsel About?
Pharmacists need to remain aware of certain interactions that can occur with medications and nutraceuticals.
What Role Do Pharmacists Play in Educating About Nutraceuticals?
Patients can use guidance about what vitamin products to select for their use.
Getting Patients to Take an Active Role in Their Own Care
Eric Peacock, co-founder and CEO of MyHealthTeams, discusses the importance of specialty pharmacies collaborating with patients in their care.
Maintaining Adherence as Out of Pocket Costs Rise
Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how specialty pharmacy can help patients manage high out of pocket costs for specialty drugs.
The Long-Term Impact of Biosimilars
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.
How Value-based Care Could Affect Specialty Pharmacy
Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses the potential impact of value-based care on specialty pharmacy.
Effective Medication Therapy Management in Specialty Pharmacy
Jonathan Van Lare, PharmD, director of Clincal Services at Pharmacy Advantage, discusses the elements of a successful specialty pharmacy therapy management program.
Scrutiny Continues to Grow Around the Cost of Specialty Drugs
Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.
Greater Competition and Specialty Drug Costs
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses whether increased competition for specialty drugs can lower costs.
How Can Pharmacists Maintain Adherence?
Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses methods pharmacists can employ to maintain adherence.
Quality Metrics That Define Specialty Pharmacy
Daniel P. Kus, BS Pharm, RPh, vice president, Pharmacy Advantage, discusses key quality measures that define successful specialty pharmacies.
High Cost Impacts PCSK9 Inhibitor Access
Mark Tesell, PharmD, BCPS, discusses how the high cost of PCSK9 inhibitors effected uptake of the cholesterol-lowering drug.
Access to High Cost Drugs Remains a Challenge in Specialty
Paul LeVine, vice president of Analytic Services at Trial Card, discusses potential ways to overcome the hurdle of limited access to high cost specialty drugs.
The Key to Effective Patient Management in Specialty Pharmacy
Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses the elements of a successful therapy management program in specialty pharmacy.
Demonstrating Quality Under a Value-Based Insurance Design
Marc O'Connor, COO and chief strategy officer for Curant Health, discusses how specialty pharmacies can demonstrate value as the use of value-based care designs increase.
Managing Patients on PCSK9 Inhibitors
Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses utilization management issues with a PCSK9 inhibitor regimen for high cholesterol.
Challenges Managing Patients in Long-Term Care
Deborah Michaelson, MS, RPh, discusses various challenges that accompany patient support in the long-term care setting.
Challenges Integrating Technology into Specialty Pharmacy
Gregory R. Morris, chief commercial officer at VirMedica, discusses hurdles with the use of eAccess technology in specialty pharmacy.
How to Improve Patient Access to Expensive Drugs
Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses how specialty pharmacies can help patients access high cost specialty drugs.
How Collaborative Care Programs Can Benefit Specialty Pharmacy
Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how collaborative care programs among providers can benefit patients undergoing treatment.
Medicare Part D and Oncology
Marc O'Connor, COO and chief strategy officer at Curant Health, discusses how the shift to Medicare Part D could impact patients undergoing treatment for cancer.
